Knight Sara J, Nathan Derek P, Siston Amy K, Kattan Michael W, Elstein Arthur S, Collela Kathleen M, Wolf Michael S, Slimack Nicholas S, Bennett Charles L, Golub Robert M
San Francisco VA Medical Center, Department of Psychiatry, University of California at San Francisco, CA, USA.
Clin Prostate Cancer. 2002 Sep;1(2):105-14. doi: 10.3816/cgc.2002.n.012.
This pilot study evaluates a shared decision-making approach to individual decision making in localized prostate cancer care. The approach is based on a decision analytic model that incorporates patient utilities, ie, patient preferences among possible health states that might occur with prostate cancer treatments. Data on comorbidities, histologic grade of the biopsy, and age were obtained for 13 patients with newly diagnosed localized prostate cancer who received care in a Veterans Administration medical center. Using a standard gamble technique, interviewers obtained patient utilities for 5 distinct health states related to prostate cancer treatment. Utilities and patient clinical and pathologic characteristics were incorporated into the decision analytic model, and the derived quality-adjusted life expectancies were shared with the treating urologist before the first patient-physician discussion about treatment options. The results of the pilot study raised 2 major concerns. First, 4 patients had utility scores of 1.0 for all of the possible health states, and 7 patients had inconsistent utilities in which they rated both impotence and incontinence as a better health state than having just one of these problems. Second, the model recommended radiation therapy to individuals with a broad range of clinical characteristics, pathologic findings, and utility scores. Many of the patients who were recommended radiation therapy by the model received discordant recommendations from the treating urologist. Future refinements of both the utility assessment exercise and decision analytic model may be needed before the feasibility of the model in the clinical setting can be determined.
这项初步研究评估了一种用于局部前列腺癌治疗中个体决策的共同决策方法。该方法基于一个决策分析模型,该模型纳入了患者效用,即患者在前列腺癌治疗可能出现的各种健康状态之间的偏好。从在退伍军人管理局医疗中心接受治疗的13例新诊断的局部前列腺癌患者中获取了合并症、活检组织学分级和年龄的数据。访谈者使用标准博弈技术,获取了患者对与前列腺癌治疗相关的5种不同健康状态的效用值。将效用值以及患者的临床和病理特征纳入决策分析模型,并在首次医患讨论治疗方案之前,将得出的质量调整生命预期告知主治泌尿科医生。初步研究结果引发了两个主要问题。首先,4例患者对所有可能的健康状态的效用值均为1.0,7例患者的效用值不一致,他们将阳痿和尿失禁均评为比仅出现其中一个问题更好的健康状态。其次,该模型向具有广泛临床特征、病理结果和效用值的个体推荐放射治疗。模型推荐放射治疗的许多患者从主治泌尿科医生那里得到了不一致的建议。在确定该模型在临床环境中的可行性之前,可能需要对效用评估方法和决策分析模型进行进一步完善。